Regarding the administration method, it was reported that the local administration of the TLR7 agonist imiquimod with anti-CD40 immunotherapy exhibited a strong antitumour effect in a murine model of malignant mesothelioma [25]. The gene discussed is TLR7; the disease is malignant mesothelioma.